跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AS-10
首页
药物
AS-10
AS-10
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
10-(DI(PHENYL)METHYL)-4-HYDROXY-8,9,9A,10-TETRAHYDRO-7H-PYRROLO[1',2':4,5]PYRAZINO[1,2-B]PYRIDAZINE-3,5-DIONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE ORTHOMYXOVIRUS REPLICATION FOR TREATING INFLUENZA
EP 3759113 B1
申请人: NOVARTIS AG
优先权: 2018
EP
US
WO
7 件公开
Pyrazine compounds as phosphodiesterase 10 inhibitors
US 8053438 B2
申请人: AMGEN INC
优先权: 2009
US
7 件公开
Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
US 7550465 B2
申请人: ELBION GMBH
优先权: 2006
CN
US
4 件公开
Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)
US 8772316 B2
申请人: LEBLOND BERTRAND
优先权: 2012
CN
US
4 件公开
10-Hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists
US 7169807 B2
申请人: ALLERGAN INC
优先权: 2004
US
4 件公开
2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17beta-hydroxy steroid dehydrogenase type 1
US 7435757 B2
申请人: SCHERING AG
优先权: 2005
US
4 件公开
Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
US 8318718 B2
申请人: ALLEN JENNIFER R
优先权: 2009
US
4 件公开
IL-10/fc Fusion Proteins Useful As Enhancers Of Immunotherapies
US 2022370564 A1
申请人: ECOLE POLYTECHNIQUE FED LAUSANNE EPFL
优先权: 2019
CN
US
WO
3 件公开
Diebenzofuran derivatives as inhibitors of PDE-4 and PDE-10
US 8263648 B2
申请人: BALASUBRAMANIAN GOPALAN
优先权: 2006
CN
US
3 件公开
ARYL AND HETEROARYL FUSED IMIDAZO[1,5-a]PYRAZINES AS INHIBITORS OF PHOSPHODIESTERASE 10
US 2009143367 A1
申请人: ELBION GMBH
优先权: 2008
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈